Affiliation:
1. Moscow State University of Medicine and Density n. a. A. I. Evdokimov
Abstract
The article presents modern data on the formation and manifestations of multiple metabolic disorders with an emphasis on the features of pathology in old age. Age-related changes in nutrition, physical activity, carbohydrate and lipid metabolism are additional risk factors for the development of metabolic syndrome and determine the high prevalence of this pathology in old age. Multiple metabolic disorders aggravate the course of each of them and worsen the prognosis due to high risks of cardiovascular and other types of mortality. Timely diagnosis and effective correction of metabolic syndrome manifestations will reduce these risks and increase life expectancy while improving its quality. In order to increase the effectiveness of basic therapy of metabolic disorders, the use of drugs capable of positively affecting multiple metabolic disorders has been shown. In particular, this paper provides an evidence base for the effectiveness of taurine in patients with metabolic syndrome. When using taurine in addition to basic standard therapy, there is a significant decrease in blood pressure, glucose levels, insulin, serum lipid spectrum, body mass index.
Publisher
LLC Global Media Technology
Subject
Gastroenterology,Hepatology
Reference39 articles.
1. Clinical guidelines for the diagnosis and treatment of metabolic syndrome, Available: https://mzdrav.rk.gov.ru/file/mzdrav18042014_Klinicheskie_rekomendaciiMetabolicheskij sindrom.pdf, (2013), Access: 07/02/2021.@@ Klinicheskie rekomendatsii po diagnostike i lecheniyu metabolicheskogo sindroma, https://mzdrav.rk.gov.ru/file/mzdrav18042014_Klinicheskie_rekomendaciiMetabolicheskij sindrom.pdf, (2013), obrashchenie ot 02.07.2021.
2. Mychka V.B., Vertkin A. L., Vardaev L. I., et al. Experts’ consensus on the interdisciplinary approach towards the management, diagnostics, and treatment of patients with metabolic syndrome. Cardiovascular Therapy and Prevention. 2013;12(6):41-82. (In Russ.)@@ Mychka V. B., Vertkin A. L., Vardaev L. I. i soavt. Konsensus ekspertov po mezhdistsiplinarnomu podkhodu k vedeniyu, diagnostike i lecheniyu bol'nykh s metabolicheskim sindromom. Kardiovaskulyarnaya terapiya i profilaktika. 2013;12(6):41-82.
3. Eslam M., Newsome P. N., Sarin S. K., et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol. 2020;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039
4. Eslam M., Sanyal A. J., George J.; International Consensus Panel. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology. 2020;158(7):1999-2014.e1. doi:10.1053/j.gastro.2019.11.312.
5. Angulo P, Kleiner DE, Dam-Larsen S et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes patients with nonalcoholic fatty liver disease. Gastroenterology. 2015 Aug;149(2):389-97.e10. doi: 10.1053/j.gastro.2015.04.043.